# Extramedullary Involvement in T/Myeloid Mixed Phenotype Acute Leukemia With BCR::ABL1 Fusion in a Hispanic Female Patient: A Case Report

**Authors:** Camille L Santiago-Negron, José M Cordero Hernández, William D Marrero-León, María D Rivera Rolón

PMC · DOI: 10.7759/cureus.85214 · Cureus · 2025-06-01

## TL;DR

A rare case of T/myeloid mixed phenotype acute leukemia with BCR::ABL1 fusion and extramedullary involvement is reported in a 61-year-old Hispanic woman.

## Contribution

This case report highlights the diagnostic challenges of a rare leukemia subtype with extramedullary presentation and BCR::ABL1 fusion.

## Key findings

- A 61-year-old Hispanic female presented with generalized lymphadenopathy and extramedullary disease.
- The case exhibited T/myeloid MPAL with BCR::ABL1 fusion detected via FISH analysis.
- Integrated morphology, immunophenotyping, and molecular testing were critical for diagnosis.

## Abstract

Mixed phenotype acute leukemia (MPAL) is a rare subtype of acute leukemia characterized by the expression of markers from more than one lineage. The T/myeloid subtype, especially with extramedullary involvement and BCR::ABL1 fusion, is exceptionally rare and diagnostically challenging. We report a case of a 61-year-old Hispanic female patient presenting with generalized lymphadenopathy. Excisional biopsy of a left occipital lymph node showed diffuse effacement by a monomorphic population of blasts. Immunohistochemistry revealed co-expression of myeloid (partial MPO, lysozyme) and T-lineage markers (CD3, CD4, CD5, CD7). Bone marrow biopsy confirmed MPAL with extensive infiltration by CD3+, CD5+, and CD2+ cells; approximately 20-30% co-expressed CD34, CD117, and TdT. Flow cytometry supported a diagnosis of T/Myeloid MPAL. Fluorescence in situ hybridization (FISH) analysis identified BCR::ABL1 rearrangement. This case highlights the importance of integrating morphology, immunophenotyping, and molecular testing to diagnose MPAL and underscores the need for clinical awareness of its varied presentations, including extramedullary disease.

## Linked entities

- **Genes:** BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613], ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) [NCBI Gene 25]
- **Proteins:** MPO (myeloperoxidase), lysozyme (lysozyme 1-like), cd.3 (Cd.3 conserved hypothetical protein), CD4 (CD4 molecule), CD5 (CD5 molecule), CD7 (CD7 molecule), CD34 (CD34 molecule), KIT (KIT proto-oncogene, receptor tyrosine kinase), DNTT (DNA nucleotidylexotransferase), CD2 (CD2 molecule)
- **Diseases:** Mixed phenotype acute leukemia (MONDO:0020743)

## Full-text entities

- **Genes:** CD7 (CD7 molecule) [NCBI Gene 924] {aka GP40, LEU-9, TP41, Tp40}, MPO (myeloperoxidase) [NCBI Gene 4353], CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, CD34 (CD34 molecule) [NCBI Gene 947], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}
- **Diseases:** MPAL (MESH:D015456), T/Myeloid MPAL (MESH:D015470), T (MESH:D001260), Myeloid (MESH:D007951)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12221112/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12221112/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12221112/full.md

---
Source: https://tomesphere.com/paper/PMC12221112